Hiv

PHILADELPHIA — Pitavastatin lowered noncalcified plaque volume and reduced risk for plaque progression compared with placebo in patients with HIV at low to moderate risk for CVD, according to new data from the REPRIEVE trial.

Researchers found that implementing generic PrEP programs for young men who have sex with men at risk for HIV — a group known to have adherence and engagement issues — would reduce new infections and be cost-effective.

The number of adolescents with a prescription for HIV prevention medication increased by more than 75% during the first 3-plus years the medicine was available to them, according study findings published in Pediatrics.

Scientists have successfully developed the first vaccines against malaria and respiratory syncytial virus, but other vaccine targets remain.

BOSTON — A single dose of benzathine penicillin G is effective against early syphilis regardless of HIV status, according to a study presented at IDWeek.

Using physiologically based pharmacokinetic modeling combined with observed clinical data, researchers determined that obesity can lead to reduced exposure and response to antiretroviral drugs.

BOSTON — The Infectious Diseases Society of America Foundation named Edsel Salvana, MD, DTM&H, FDCP, FIDSA, its sixth IDea Incubator Innovator of the year at IDWeek for portable HIV drug resistance testing.

Thirty-day hospital readmissions decreased among patients in HIV care in the United States and Canada from 2005 to 2018, researchers reported.

Weight gain and body composition changes that follow ART initiation are associated with long-term risks of cardiovascular and metabolic diseases, researchers reported.